Cc1nc(C(=O)NCCC(C)C)sc1C1(C)CC(c2cccc([N+](=O)[O-])c2)=NO1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?